↓ Skip to main content

Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level

Overview of attention for article published in Annals of Hematology, May 2011
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Readers on

mendeley
18 Mendeley